| Literature DB >> 33750983 |
Camila Mareti Bonin-Jacob1,2, Larissa Zatorre Almeida-Lugo1, Marco Antonio Moreira Puga1, Ana Paula Machado3, Cacilda Tezelli Junqueira Padovani2, Mariana Calarge Noceti2, Alda Maria Teixeira Ferreira2, Carlos Eurico Dos Santos Fernandes2, Júlio César Possati Resende4, Adriane Cristina Bovo5, Inês Aparecida Tozetti3.
Abstract
Persistent infection by high-risk human papillomavirus (HR-HPV) is the main cause of cervical cancer and its precursor lesions. While some cytokines help immune cells in virus clearance, others contribute to the persistence of infection and neoplastic progression. Here, the levels of interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-10, IL-6, IL-4, and IL-2 were quantified in the serum and exfoliated cervical cells (ECCs) of patients with HR-HPV, and the presence of IL-6+ cells was investigated in uterine cervix biopsies. Cytokine levels in the serum and ECCs of 26 HR-HPV DNA-positive patients and 18 HPV DNA-negative patients were measured using flow cytometry. Fifteen uterine cervix biopsy samples embedded in paraffin were subjected to immunohistochemical analysis for the detection of IL-6+ cells. HR-HPV-positive patients showed increased IL-6 and IL-10 in the ECCs and serum, respectively. Compared with HPV DNA-positive patients, HPV DNA-negative patients had higher levels of IL-6 in ECCs. Patients with multiple infections of HPV had higher levels of IL-6 in their ECCs than those with a single infection. Immunostaining of uterine cervix biopsy samples revealed no differences in IL-6 expression between the different classes of histopathological lesions. However, differences were observed in the expression levels of IL-6 and IL-10 at the systemic and local levels in HR-HPV-positive patients without cervical lesions. Considering the functional characteristics of these cytokines, it can be inferred that such patients are prone to persistent HPV infection.Entities:
Year: 2021 PMID: 33750983 PMCID: PMC7984643 DOI: 10.1371/journal.pone.0248639
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240